In This Section

Recent Press Releases

December 5, 2016

Transaction provides new royalty and potential milestone revenues, opportunity to reduce cost structure, and continuity of patient access to lomitapide

November 29, 2016

-- Transaction creates strong, diversified rare-disease focused portfolio

-- Novelion Therapeutics completes concurrent financing of approximately $22 million

-- Company to host conference call today at 4:30 p.m. ET